• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

27 例印度患者定量纤维蛋白原紊乱的分子基础。

Molecular basis of quantitative fibrinogen disorders in 27 patients from India.

机构信息

Department of Hematology, Christian Medical College, Vellore, India.

出版信息

Haemophilia. 2013 Jul;19(4):611-8. doi: 10.1111/hae.12143. Epub 2013 Apr 8.

DOI:10.1111/hae.12143
PMID:23560673
Abstract

Congenital fibrinogen deficiency is an extremely rare (1:1 000 000) hereditary bleeding disorder caused by defects in genes coding for fibrinogen Aα-, Bβ- and γ-chains, respectively. We report here the molecular basis of fibrinogen deficiency in a large series of patients from India. Twenty-seven patients with clinical features suggestive of fibrinogen deficiency and with prolonged plasma clotting times and low fibrinogen levels were studied. Genomic DNA was screened for mutations in the fibrinogen alpha (FGA), beta (FGB), gamma (FGG) genes by PCR and conformation sensitive gel electrophoresis. Fourteen different disease-causing mutations including frameshifts (51.9%), splice site (22.2%), missense (18.5%) and nonsense mutation (7.4%) were identified in 27 patients. Thirteen of them were novel, including seven frameshifts (fibrinogen Aα: p.Asp296 fs59, p.Thr466 fs17 and p.Lys575 fs74; fibrinogen Bβ: p.Gly414 fs2 and fibrinogen γ: p.Ser81 fs5, p.Lys185 fs13 and p.Asp278_279 fs17), three splice site mutations (FGA gene c.364+1G>A; c.510+2 T>G; FGB gene c.851+1G>A), two missense substitutions (fibrinogen Bβ: p.Gly288Ser; p.Arg445Thr) and a nonsense mutation in fibrinogen Aα (p.Tyr127). Two common mutations (FGA: c.364+1G>A, n = 6, FGG: p.Lys185 fs*13, n = 7) affecting 13 patients were identified in this series, suggesting that these mutations could be screened first in Indian patients with fibrinogen deficiency. The molecular data presented here is the largest series of patients with fibrinogen deficiency reported so far, adding significantly to the mutation database of this condition. It also helps create an algorithm for its genetic diagnosis in India.

摘要

先天性纤维蛋白原缺乏症是一种极其罕见的遗传性出血性疾病(1:1 000 000),由纤维蛋白原 Aα-、Bβ-和 γ-链编码基因的缺陷引起。我们在此报告来自印度的一系列患者的纤维蛋白原缺乏症的分子基础。对 27 例具有纤维蛋白原缺乏临床特征、血浆凝固时间延长和纤维蛋白原水平降低的患者进行了研究。通过 PCR 和构象敏感凝胶电泳筛选纤维蛋白原 alpha(FGA)、beta(FGB)和 gamma(FGG)基因的基因突变。在 27 例患者中鉴定出 14 种不同的致病突变,包括移码突变(51.9%)、剪接位点突变(22.2%)、错义突变(18.5%)和无义突变(7.4%)。其中 13 种是新的,包括 7 种移码突变(纤维蛋白原 Aα:p.Asp296 fs59、p.Thr466 fs17 和 p.Lys575 fs74;纤维蛋白原 Bβ:p.Gly414 fs2 和纤维蛋白原 γ:p.Ser81 fs5、p.Lys185 fs13 和 p.Asp278_279 fs17)、3 种剪接位点突变(FGA 基因 c.364+1G>A;c.510+2 T>G;FGB 基因 c.851+1G>A)、2 种错义替换(纤维蛋白原 Bβ:p.Gly288Ser;p.Arg445Thr)和纤维蛋白原 Aα 的无义突变(p.Tyr127)。在该系列中,鉴定出 13 例患者的两种常见突变(FGA:c.364+1G>A,n=6,FGG:p.Lys185 fs*13,n=7),提示这些突变可首先在印度纤维蛋白原缺乏症患者中进行筛选。目前报道的纤维蛋白原缺乏症患者的分子数据是迄今为止最大的系列,大大增加了该疾病的突变数据库。它还有助于在印度建立其遗传诊断算法。

相似文献

1
Molecular basis of quantitative fibrinogen disorders in 27 patients from India.27 例印度患者定量纤维蛋白原紊乱的分子基础。
Haemophilia. 2013 Jul;19(4):611-8. doi: 10.1111/hae.12143. Epub 2013 Apr 8.
2
Mutational screening of six afibrinogenemic patients: identification and characterization of four novel molecular defects.六例无纤维蛋白原血症患者的突变筛查:四种新分子缺陷的鉴定与特征分析
Thromb Haemost. 2007 Apr;97(4):546-51.
3
FGB mutations leading to congenital quantitative fibrinogen deficiencies: an update and report of four novel mutations.导致先天性纤维蛋白原定量缺乏的FGB突变:最新情况及四个新突变的报告
Thromb Res. 2014 May;133(5):868-74. doi: 10.1016/j.thromres.2014.01.022. Epub 2014 Jan 25.
4
Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency.21例定量纤维蛋白原缺乏症患者的临床和分子特征
Thromb Haemost. 2015 Mar;113(3):567-76. doi: 10.1160/TH14-07-0629. Epub 2014 Nov 27.
5
Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families.先天性无纤维蛋白原血症:在两个突尼斯家族中发现并鉴定出两种新型纯合子纤维蛋白原 Aα 和 Bβ 链突变。
Thromb Res. 2016 Jul;143:11-6. doi: 10.1016/j.thromres.2016.04.016. Epub 2016 Apr 27.
6
Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations.导致先天性无纤维蛋白原血症的纤维蛋白原基因簇突变:最新情况及10个新突变的报告
Hum Mutat. 2007 Jun;28(6):540-53. doi: 10.1002/humu.20483.
7
Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia.对伊朗患者的分析使得能够鉴定出纤维蛋白原Bβ链基因中导致无纤维蛋白原血症的首个截短突变。
Haematologica. 2002 Aug;87(8):855-9.
8
Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation.7 名纤维蛋白原功能异常或纤维蛋白原减少症患者的分子特征:在纤维蛋白原 Bβ链中发现导致糖基化增加的新突变。
Thromb Res. 2015 Jul;136(1):168-74. doi: 10.1016/j.thromres.2015.05.007. Epub 2015 May 14.
9
Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion.先天性低纤维蛋白原血症:影响纤维蛋白原组装和分泌的两个错义突变的特征分析
Blood Cells Mol Dis. 2008 Nov-Dec;41(3):292-7. doi: 10.1016/j.bcmd.2008.06.004. Epub 2008 Aug 3.
10
Identification and functional characterization of a novel nonsense mutation in FGA accounting for congenital afibrinogenemia in six Egyptian patients.在六名埃及患者中鉴定出FGA基因的一种新型无义突变并对其进行功能表征,该突变导致先天性纤维蛋白原血症。
Blood Coagul Fibrinolysis. 2010 Mar;21(2):164-7. doi: 10.1097/MBC.0b013e32833678d5.

引用本文的文献

1
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database.先天性纤维蛋白原异常症:前瞻性罕见出血性疾病数据库的回顾性临床与遗传学分析。
Blood Adv. 2024 Mar 26;8(6):1392-1404. doi: 10.1182/bloodadvances.2023012186.
2
Structural and Functional Characterization of Four Novel Fibrinogen Mutations in Causing Congenital Fibrinogen Disorder.四种新型纤维蛋白原突变导致先天性纤维蛋白原紊乱的结构和功能特征。
Int J Mol Sci. 2022 Jan 10;23(2):721. doi: 10.3390/ijms23020721.
3
Extension of the Human Fibrinogen Database with Detailed Clinical Information-The αC-Connector Segment.
扩展人类纤维蛋白原数据库,包含详细的临床信息- αC-连接子片段。
Int J Mol Sci. 2021 Dec 23;23(1):132. doi: 10.3390/ijms23010132.
4
Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets.激活的凝血酶激活的纤溶抑制物(TAFIa)可减弱在凝血酶激活的血小板上纤维蛋白依赖性纤溶酶原的生成。
J Thromb Haemost. 2020 Sep;18(9):2364-2376. doi: 10.1111/jth.14950.
5
Fibrinogen αC domain: Its importance in physiopathology.纤维蛋白原αC结构域:其在生理病理学中的重要性。
Res Pract Thromb Haemost. 2019 Feb 15;3(2):173-183. doi: 10.1002/rth2.12183. eCollection 2019 Apr.
6
Identification of novel mutations in patients with fibrinogen disorders and genotype/phenotype correlations.鉴定纤维蛋白原紊乱患者的新型突变与基因型/表型相关性。
Blood Transfus. 2019 May;17(3):247-254. doi: 10.2450/2018.0123-18. Epub 2018 Oct 8.
7
Clinical Consequences and Molecular Bases of Low Fibrinogen Levels.低纤维蛋白原水平的临床后果和分子基础。
Int J Mol Sci. 2018 Jan 8;19(1):192. doi: 10.3390/ijms19010192.
8
Identification of novel mutations in congenital afibrinogenemia patients and molecular modeling of missense mutations in Pakistani population.先天性无纤维蛋白原血症患者新突变的鉴定及巴基斯坦人群错义突变的分子建模
Thromb J. 2017 Sep 12;15:24. doi: 10.1186/s12959-017-0143-3. eCollection 2017.
9
Molecular pathology of rare bleeding disorders (RBDs) in India: a systematic review.印度罕见出血性疾病(RBDs)的分子病理学:一项系统综述。
PLoS One. 2014 Oct 2;9(9):e108683. doi: 10.1371/journal.pone.0108683. eCollection 2014.